EZH2 gene
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (18)
Papers in which this entity is mentioned.
- Integrative epigenetics and transcriptomics identify aging genes in human blood. (2026)
- RNA splicing dysregulation and the hallmarks of cancer. (2023)
- Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
- Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. (2019)
- The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer. (2018)
- Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. (2017)
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
- The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies. (2016)
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. (2015)
- Design and bioinformatics analysis of genome-wide CLIP experiments. (2015)
- Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. (2015)
- Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. (2014)
- Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. (2014)
- EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. (2014)
- Cancer genome landscapes. (2013)
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. (2013)
- The genomic landscape of hypodiploid acute lymphoblastic leukemia. (2013)
- Novel mutations target distinct subgroups of medulloblastoma. (2012)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ezh2 | gene | 35 | 124 |
| enhancer of zeste homolog 2 | gene | — | — |